Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adiponectin receptor family, primarily AdipoR1 and AdipoR2, mediates the physiological effects of adiponectin. These receptors are crucial for regulating glucose and lipid metabolism, energy homeostasis, insulin sensitivity, and inflammatory responses. They activate AMPK and PPARα pathways, promote fatty acid oxidation and glucose uptake, and possess intrinsic ceramidase activity. They are considered promising therapeutic targets for metabolic diseases such as type II diabetes.
Agonists bind to AdipoR1 and AdipoR2, activating AMPK and PPARα pathways, promoting fatty acid oxidation and glucose uptake, and hydrolyzing ceramide into sphingosine and fatty acid.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adiponectin Receptor (AdipoR).